Partial myeloid inhibition of key glycolytic enzyme PFKFB3 increases hepatic steatosis and inflammation, but does not affect atherosclerosis

Saved in:
Bibliographic Details
Published in:Atherosclerosis 2023-08, Vol.379, p.S29-S30
Main Authors: Tillie, R., De Bruijn, J., Dobie, R., Perales-Patón, J., Van Kuijk, K., Gijbels, M., Temmerman, L., Ghosheh, Y., Goossens, G., Carmeliet, P., Ley, K., Henderson, N., Saez-Rodriguez, J., Wouters, K., Sluimer, J.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0021-9150
DOI:10.1016/j.atherosclerosis.2023.06.961